How To Solve The Big Challenges Of Cell And Gene Therapy Manufacturing

By Johanna Blair, Staff Writer, MasterControl

The field of cell and gene therapies (CGT) is experiencing an unprecedented surge in investment, innovation, and enthusiasm. These advanced therapies hold the promise of transforming the treatment landscape for a wide range of diseases to offer hope where traditional medicine has fallen short. As a result, CGT manufacturing has rapidly emerged as one of the fastest-growing sectors within the life sciences industry. However, while the science behind these therapies is often groundbreaking, the manufacturing processes required to bring them to scale frequently lag behind. Many operations still rely on outdated systems and methodologies, which create significant bottlenecks in the journey from lab to patient. This disconnect between scientific advancement and manufacturing capability presents a critical challenge—and an opportunity—for those ready to lead the next wave of innovation in CGT production.

Now is the time to modernize and invest in scalable, future-ready manufacturing solutions. Bring your CGT manufacturing into the future.